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Abstract  
The Authors report a case of alopecia areata totalis in a woman with Turner syndrome. 
Introduction 
 
Alopecia areata (AA) is an inflammatory non-
scarring form of hair loss, which may involve all the 
follicular units of the body. It is a common disease, 
with an incidence of 1-2% [1]. 
AA may affect people of both sex and all age, 
even if it is more commonly described in under 30-
years old patients [2]. Often, it is associated with 
different inflammatory or autoimmune diseases, like 
atopic eczema, Hashimoto’s thyroiditis, Graves’ 
disease, Celiac disease, vitiligo, psoriasis and others 
[1]. 
AA is an autoimmune disease, characterised 
by a T-cell mediated immune response that targets 
hair follicles. The clinical manifestations are 
numerous, ranging from mild lesions, characterised by 
round or oval patches of hair loss, to the total hair 
loss, such as in the universal form [3]. 
 
 
Case report 
 
A 28-year-old woman affected by AA, showed 
up to our Clinic presenting a widespread non-scarring 
alopecia, which was localised in the scalp and face 
area. The skin was white-pink in colour and normal-
trophic. Black dots and exclamations points were no 
detected. Only a few vellus-like hairs were present in 
the midline of the scalp (Fig.1).The patient did not 
report any subjective symptoms and enjoyed apparent 
good health. 
She reported the appearance of the disease 
about 26 months ago. Initially, the hair loss was 
limited to the left temporal side, and consisted in two 
round little (diameter less than 2 cm), well defined, 
areas. After few weeks, the hair loss rapidly spread, 
involving the entire scalp. By five months, the patient 
also observed the loss of her eyelashes and 
eyebrows. 
The woman told us to be affected by Turner 
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syndrome, Hashimoto’s thyroiditis and celiac disease. 
Her medical treatment consisted of oral levothyroxine 
and oestrogen replacement. No other diseases had 
been reported. She had no familiarity for AA or other 
autoimmune diseases. 
The patient reported previous treatment of 
alopecia with oral supplements and topical minoxidil 
2% 1 ml twice a day for six months. Due to the lack of 
clinical improvement, she was treated with low dose of 
topical corticosteroids (hydrocortisone once a day) for 
three weeks and PUVA therapy, which has been 
performed twice a week for a total of 20 sessions, 
both without beneficial results. 
 
Figure 1: Alopecia areata in a woman with Turner syndrome 
 
During the clinical evaluation, the woman 
showed characteristic features of Turner syndrome, 
such as short stature (150 cm), short and squat neck, 
poor breast development and stubby little hands. She 
had ears and lower eyelids bigger than normal, 
enophthalmos, reduced upper lip and a small chin. On 
the other hand, no other skin lesions were observed. 
Nails were smaller than normal. A routine laboratory 
test, including thyroid function tests, were normal. 
 
Figure 2: Eyelashes and eyebrows re-growth after cyclosporine A 
therapy 
 
Due to the long duration of the hair disease, 
we applied intralesional triamcitolone acetonide once 
a week for two months. Surprisingly, even if localised, 
we observed a re-growth of the hair. Since hair growth 
responded to corticosteroids, we switched to oral 
methylprednisolone 32 mg/die for ten days, followed 
by 16 mg/die for ten days and, eventually 8 mg/die for 
another ten days. The clinical response was quite 
good: the patient showed new hair in the frontal area 
of the scalp. 
 
Figure 3: So we prescribed oral cyclosporine A 300 mg/die for two 
months, and intralesional triamcitolone acetonide once every two 
weeks. Due to the good clinical response to the therapy and the 
possible side effects of corticosteroids, after two months, we 
decided to prescribe the only cyclosporine A 200 mg/die 
 
After one month, we observed the diffuse hair 
re-growth on the scalp. New eyelashes and eyebrows 
were also observed (Fig.2). 
We decided to reduce progressively the 
cyclosporine therapy and to stop it. Because of the 
appearance of new hair loss patches (Fig.3), the 
patient re-started the treatment with cyclosporine A at 
a dosage of 200 mg/die. The clinical response was 
rapid and excellent (Fig.4). 
 
Figure 4: Our patient with complete hair re-growth 
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During the treatment we constantly evaluated 
the patient’s clinical conditions, monitoring her blood 
pressure and routine blood test. No side effects or 
complications had been observed. 
 
 
Discussion 
 
Turner syndrome (or Ullrich-Turner syndrome) 
is one of the most frequent chromosomal 
abnormalities, which results from a sex-chromosomal 
anomaly characterised by a presence of one normal X 
chromosome and a missing or structurally abnormal 
second sex chromosome. It is a rare disease affecting 
1:2500 live born girls [4]. 
Table 1: Characteristic clinical features of Turner syndrome 
Skin and adnexa 
pterygium; ↑ moles; vitiligo; ↑ growth of body hair 
(forearm); low-set hair; ↓ hair density; congenital 
lymphedema of the hands and feet; over the curvature of 
the nails 
Mouth 
palate with a pointed arch form ("Gothic“ palate); ↓ 
development of the jaw; mouth as a "carp." 
Ears 
low implantation; ↓ development of the ear’s board; large 
ears; others malformations; neurosensorial defects  
Eyes 
alteration in the position and shape of the eyelid 
(hypertelorism and epicanthal folds); strabismus; 
dyschromatopsia 
Neck short and squat 
Skeletal system 
short fingers; widened distal phalanges;  ↓ length of the 
fourth metacarpal bone (XR Archibald sign); cubitus 
valgus; medial condyle of the tibia agenesia (XR Kosowicz 
sign); delayed bone maturation (first three years of life, 
after ten years)  
Chest 
enlarged; pectus excavatum; hypoplasia and the 
excessive distance between the mammary areola  
Urinary system 
horseshoe kidney; renal cysts; unilateral renal agenesis; 
pelvis and ureters alterations   
Cardiovascular system   
bicuspid aortic valve; aortic coarctation; aortic valve 
disease; anomalous venous return of the pulmonary veins; 
mitral valve prolapse; hypertension; conduction defects  
Blood abnormalities of coagulation factors 
Metabolism 
abnormal lipid profile (cholesterol, triglycerides) and 
glucose 
Nervose system 
defects in visual-spatial and visual-perceptual skills; ↓ 
motor function (unable to walk before 15 months); ↓ non-
verbal memory; ↓ attention   
Psychological disorders in emotional 
 
The Turner syndrome phenotype includes 
female gender, short stature, primary ovarian failure 
and some characteristic physical features (tab.1) [5]. 
Patients with Turner syndrome have an increased 
incidence of autoimmune disorders (AID), such as 
Hashimoto’s thyroiditis, Grave’s disease, celiac 
disease, inflammatory bowel disease, and diabetes 
mellitus [6-8]. 
Even if dermatologic autoimmune diseases 
(e.g. psoriasis, vitiligo, halo nevi) are well-known in 
Turner patients (9, 10), only a few cases of associated 
AA have been reported so far [11-13]. 
AA is a chronic inflammatory autoimmune 
disease, characterised by non-scarring hair loss on 
the scalp or any hair-bearing area of the body. 
Clinically it may represent in variable patterns, such 
as patchy, diffuse, reticulate, linear, or opiates-type. 
Depending on the severity of hair loss, AA may also 
be classified as localised (few patches of hair loss), 
subtotal (diffuse alopecia of the scalp), total (complete 
loss of scalp hair) or universal (complete loss of body 
hair) [14]. 
Table 2: Therapeutic options for alopecia areata 
Classical treatments Corticosteroids (topical, intralesional, systemic) 
 
PUVA-therapy (topical or systemic 8-Methoxypsoralen + 
UVA) 
 
Topical immunotherapy (diphenylcycloproperone/DPCP, 
squaric 
 acid dibutyl ester/SADBE) 
 Antralin cream or ointment 
Aneddotic treatments Antidepressant 
 Hypnotherapy 
 Psychological support 
 Topical minoxidil 
 Topical triiodothyronine 
 Garlic gel 
 Azelaic acid 
 Topical onion juice 
 Imiquimod 
 Botulinum toxin 
 Photodynamic therapy 
 Topical phenol 
 Excimer lasers 
Promising treatments Azathioprine 
 Methotrexate 
 Cyclosporine A (topical, systemic) 
 Tacrolimus 
 Pimecrolimus 
 Alitretinoin 
 Biological therapies 
 Platelet-rich plasma 
 UVA1 (340-400 nm) 
 
The course of the disease is highly variable: it 
may spontaneously regress, be stable or progress to 
a severe form. Even if numerous treatment options 
are now available for AA (tab.2), no definitive therapy 
exists [15, 16]. 
In our case, the patient showed an excellent 
clinical response to cyclosporine A treatment, initially 
combined with intralesional corticosteroids. 
 In conclusion, the authors have presented this 
case study to record the possible association of AA 
with Turner syndrome, and therapeutic validity of 
cyclosporine in stimulating hair growth where other 
therapies had previously failed. 
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